Latest Posts

22

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

27

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

kol discovery

Build KOL Connections and Leverage Their Networks to Influence Stakeholders

Key opinion leaders (KOLs) play a central role in creating brand value for a pharmaceutical company. They are not only the face of the brand for the outside world but also an irreplaceable resource within the company, bringing new insights and overall enhancement throughout the drug development process. So, who are the KOLs? When a …

Build KOL Connections and Leverage Their Networks to Influence Stakeholders Read More »

Can AI-Enhanced Data Analytics Accelerate Clinical Trials?

The success rate of clinical trials carries significant weight in the business of pharma. In addition to dedicating considerable time and effort, the industry spends billions on R&D every year. Clinical development requires optimal decision-making and multiple insights on various parameters, including identifying trial sites, recruiting patients, coordinating logistics, and overseeing research. Adding pressure to …

Can AI-Enhanced Data Analytics Accelerate Clinical Trials? Read More »

Leveraging AI to Optimize Clinical Trial Design and Site Enrollment

The request The client wanted help with clinical trial design and assistance with site selection, patient enrollment, and identification of suitable investigators. Background and challenges The client, a mid-sized pharmaceutical company, was entering phase II clinical trials for a drug targeting diffuse large B-cell lymphoma (DLBCL). However, due to limited prior experience clinically developing an …

Leveraging AI to Optimize Clinical Trial Design and Site Enrollment Read More »

How Can AI Technologies Help Streamline Medical Affairs Processes?

For pharmaceutical companies, much of the success of a new drug depends on how well it is marketed. There are various stages a drug goes through before reaching the commercialization phase, and, by necessity, focus is placed more on drug development than on marketing. This puts a lot of pressure on commercial teams. They need …

How Can AI Technologies Help Streamline Medical Affairs Processes? Read More »

Leveraging the Role of AI for More Successful Clinical Trials

The pharmaceutical industry spends billions on R&D each year. Clinical trials require tremendous amounts of effort, from identifying sites and enrolling patients to overseeing research functions and coordinating trial logistics. Trials often run over budget or are delayed because of a number of factors, such as an inadequate number of patients available for the study, …

Leveraging the Role of AI for More Successful Clinical Trials Read More »